SRPT FY 2013 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M-61.9% YoY

Gross Profit

-$76M-535.0% margin

Operating Income

-$90M-635.0% margin

Net Income

-$112M-787.6% margin

EPS (Diluted)

$-3.31

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$68M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$292M

Total Liabilities

$44M

Stockholders' Equity

$247M

Cash & Equivalents

$257M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$37M	-61.9%
Gross Profit	-$76M	-$15M	-420.9%
Operating Income	-$90M	-$30M	-204.0%
Net Income	-$112M	-$121M	+7.7%